TDSPHARM Co., Ltd. Logo

TDSPHARM Co., Ltd.

Develops transdermal drug delivery systems, OTC medicines, and cosmetic products.

464280 | KO

Overview

Corporate Details

ISIN(s):
KR7464280007
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 판교로 253 C동 403호, 성남시

Description

TDSPHARM Co., Ltd. is a pharmaceutical company specializing in the research, development, and manufacturing of Transdermal Drug Delivery Systems (TDDS), where active ingredients are absorbed through the skin. The company focuses on creating safe and effective medicinal products through dedicated R&D efforts. Its product portfolio includes a variety of TDDS-based items such as medical cataplasmas, plasters, and patches for applications like pain relief and antibiotic delivery. In addition to its core pharmaceutical business, TDSPHARM also develops and manufactures Over-The-Counter (OTC) medicines and cosmetic products, aiming to provide a wide selection of accessible healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-02 00:00
주식등의대량보유상황보고서(일반)
Korean 86.7 KB
2025-09-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 814.7 KB
2025-05-14 00:00
분기보고서 (2025.03)
Korean 783.5 KB
2025-05-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-02 00:00
주식등의대량보유상황보고서(일반)
Korean 89.0 KB
2025-04-09 00:00
주식등의대량보유상황보고서(약식)
Korean 64.5 KB
2025-04-03 00:00
주식등의대량보유상황보고서(일반)
Korean 90.5 KB
2025-04-02 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-03-25 00:00
정기주주총회결과
Korean 19.6 KB
2025-03-17 00:00
감사보고서제출
Korean 18.0 KB
2025-03-17 00:00
사업보고서 (2024.12)
Korean 437.1 KB
2025-03-17 00:00
[기재정정]사업보고서 (2024.12)
Korean 1013.2 KB
2025-03-10 00:00
주주총회소집공고
Korean 101.9 KB
2025-02-07 00:00
주주총회소집결의
Korean 7.1 KB

Automate Your Workflow. Get a real-time feed of all TDSPHARM Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for TDSPHARM Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for TDSPHARM Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.